Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Checkpoint Therapeutics Inc shares valued at $2,330,386 were sold by Oliviero James F III on Dec 18 ’24. At $3.87 per share, Oliviero James F III sold 602,167 shares. The insider’s holdings dropped to 3,414,813 shares worth approximately $11.37 million following the completion of this transaction.
Also, Oliviero James F III sold 220,230 shares, netting a total of over 744,377 in proceeds. Following the sale of shares at $3.38 each, the insider now holds 3,194,583 shares.
Before that, GRAY WILLIAM GARRETT had sold 268,432 shares from its account. In a trade valued at $1,076,412, the Chief Financial Officer traded Checkpoint Therapeutics Inc shares for $4.01 each. Upon closing the transaction, the insider’s holdings decreased to 268,432 shares, worth approximately $3.44 million.
As published in their initiating research note from D. Boral Capital on January 13, 2025, Checkpoint Therapeutics Inc [CKPT] has been a Buy and the price target has been revised to $9. As of June 09, 2021, B. Riley Securities has initiated its “Buy” rating for CKPT. Earlier on January 20, 2021, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for CKPT stock.
Analyzing CKPT Stock Performance
During the last five days, there has been a surge of approximately 3.74%. Over the course of the year, Checkpoint Therapeutics Inc shares have jumped approximately 4.06%. Shares of the company reached a 52-week high of $3.77 on 01/06/25 and a 52-week low of $3.07 on 01/10/25. A 50-day SMA is recorded $3.61, while a 200-day SMA reached $2.54. Nevertheless, trading volume fell to 0.63 million shares from 0.77 million shares the previous day.
Support And Resistance Levels for Checkpoint Therapeutics Inc (CKPT)
According to the 24-hour chart, there is a support level at 3.25, which, if violated, would cause prices to drop to 3.17. In the upper region, resistance lies at 3.41. The next price resistance is at 3.50. RSI (Relative Strength Index) is 46.07 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.08, which suggests the price will decrease in the coming days. Percent R is at 62.88%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
